BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 21679902)

  • 1. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
    Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Utility of
    Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
    Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of [
    Caobelli F; Gözlügöl N; Bakula A; Rominger A; Schepers R; Stortecky S; Hunziker Munsch L; Dobner S; Gräni C
    J Nucl Med; 2024 Jun; 65(6):944-951. PubMed ID: 38724281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial scanning with
    Minutoli F; Di Bella G; Mazzeo A; Laudicella R; Gentile L; Russo M; Vita G; Baldari S
    J Nucl Cardiol; 2021 Oct; 28(5):1949-1957. PubMed ID: 31741327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
    Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
    Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac transthyretin amyloidosis
    Löfbacka V; Axelsson J; Pilebro B; Suhr OB; Lindqvist P; Sundström T
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1822-1832. PubMed ID: 33367948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of
    Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
    Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
    Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
    Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis.
    Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Cunha N; Rodrigues T; Santos L; Conceição I; Agostinho J; Pinto FJ
    Amyloid; 2024 Mar; 31(1):32-41. PubMed ID: 37493395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimized imaging protocol for [
    Schatka I; Bingel A; Schau F; Bluemel S; Messroghli DR; Frumkin D; Knebel F; Diekmann SM; Elsanhoury A; Tschöpe C; Hahn K; Amthauer H; Rogasch JMM; Wetz C
    J Nucl Cardiol; 2021 Dec; 28(6):2483-2496. PubMed ID: 34331215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.